This led to the transporter hypothesis of refractory epilepsy, which states that ABCB1 overexpression at the blood-brain barrier in epilepsy restricts antiseizure brain drug uptake, thus, leading to antiseizure drug resistance (Tang et al., 2017). This evidence concerns the gene ABCB1 and epilepsy.